Results 101 to 110 of about 16,555,945 (165)

Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors

Leukemia Research Reports
Chronic Lymphocytic Leukemia (CLL) is the most common type of leukemia in the US, representing approximately 1.1% of all new cancers diagnosed. Most patients with CLL can be monitored without treatment, and the indicated treatment options include a CD20 ...
Nkolika Nwankwo, Aswanth Reddy, Swarup Kumar, Maha Zafar   +3 more
doaj   +1 more source

Monoclonal B-cell lymphocytosis: from literature to laboratory practice

, 2016
peer reviewedMonoclonal B-cell lymphocytosis (MBL) is defined as an asymptomatic condition characterized by the presence of less than 5,000 monoclonal B-cells per microliter and the absence of clinical signs or symptoms of a B-cell lymphoproliferative ...
KEUTGENS, Aurore, Gothot, André, Tassin, Francoise, Foguenne, Jacques   +3 more
core   +1 more source

Monoclonal B-cell lymphocytosis: right track or red herring?

, 2012
"Monoclonal B-cell lymphocytosis (MBL), a newly recognized entity found in approximately 3% of normal persons, precedes chronic lymphocytic leukemia. However, MBLs progress into overt malignancy only in a very minor portion of cases, thus raising the ...
GHIA , PAOLO PROSPERO, CALIGARIS CAPPIO , FEDERICO   +1 more
core   +1 more source

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Blood, 2015
P. Strati, T. Shanafelt
semanticscholar   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Inherited genetic susceptibility to monoclonal B-cell lymphocytosis

, 2010
Monoclonal B-cell lymphocytosis (MBL) is detectable in > 3% of the general population. Recent data are compatible, at least in a proportion of cases, with MBL being a progenitor lesion for chronic lymphocytic leukemia (CLL) and a surrogate for inherited ...
Toniolo D, Crowther Swanepoel D, Lloyd A, Rossi D, ROSSI, Davide, Corre T, Bennett FL, Caligaris Cappio F, Catovsky D, Olver B, Doughty C, Rawstron AC, GHIA , PAOLO PROSPERO, GAIDANO, Gianluca, Ghia P, Houlston RS, Gaidano G   +16 more
core   +1 more source

New Insights into Monoclonal B-Cell Lymphocytosis

, 2014
Monoclonal B-cell lymphocytosis (MBL) is a premalignant condition characterized by the presence of less than 5000/L circulating clonal B cells in otherwise healthy individuals.
Kalpadakis, C., Moschogiannis, M., Sachanas, S., Pangalis, G.A., Kyrtsonis, M.-C., Tsirkinidis, P., Koulieris, E., Angelopoulou, M.K., Kyriakaki, S., Yiakoumis, X., Panayiotidis, P., Levidou, G., Papadaki, H.A., Korkolopoulou, P., Vassilakopoulos, T.P.   +14 more
core   +1 more source

SP17 | AN INTEGRATED DIAGNOSTIC APPROACH COMBINING BONE MARROW BIOPSY AND FLOW CYTOMETRY IN FOUR CHALLENGING CASES OF SMALL B-CELL LYMPHOMA WITH LEUKEMIC PRESENTATION

Haematologica
Classification of small B-cell lymphomas with leukemic presentation can be challenging in the absence of nodal involvement. We highlight the value of an integrated diagnostic approach, combining bone marrow (BM) histopathology and flow cytometry (FC ...
F. Adotti, B. Mandelli, F. Arienzo, M.G. Pignataro, S. Trasarti, L. Bizzoni, M.S. De Propris, C. Giordano   +7 more
doaj  

Rare Coexistence of Atypical Chronic Lymphocytic Leukemia and B-Acute Lymphoblastic Leukemia in a Patient Followed Up for Monoclonal B-Cell Lymphocytosis

Hemato
Monoclonal B Lymphocytosis (MBL) is considered the pre-malignant state of chronic lymphocytic leukemia (CLL) and atypical chronic lymphocytic leukemia (aCLL).
Fabio Bertani, Francesco Faiella, C. Di Franco, R. Milani, Antonella Gualdoni, C. Fulceri, E. Costa   +6 more
semanticscholar   +1 more source

A new diagnosis of monoclonal B-cell lymphocytosis with cytoplasmic inclusions in a patient with COVID-19. [PDF]

Am J Hematol, 2022
Lanza L, Koroveshi B, Barducchi F, Lorenzo A, Venturino E, Cappelli E, Lillo F, Bain BJ.   +7 more
europepmc   +1 more source